{"retracted":false,"update":{"timestamp":1416873600000,"doi":"10.1007/s00415-014-7565-7","type":"correction"},"doi":"10.1007/s00415-014-7446-0","journal":"Journal of Neurology","publisher":"Springer Nature","title":"Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial"}
